The Effect of Calcium on Renin, Aldosterone and Prostaglandin Release

  • J. L. Nadler
  • I. Antonipillai
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 208)

Abstract

Evidence suggests that calcium (Ca2+) has an important regulatory role in the control of systemic and renal vascular tone. Acute and chronic hypercalcemia can increase blood pressure (Bp) and reduce renal blood flow (1–3). In contrast, pharmacologic blockade of Ca2+ entry into vascular smooth muscle can improve many forms of hypertension (4). The mechanisms of Ca2+ induced changes in vascular tone are complex since Ca2+ can directly produce vascular smooth muscle constriction or mediate the pressor actions of vasopressin, norepinephrine and angiotensin II (AII) (5,6). In addition, other studies reviewed in this paper indicate that Ca2+ may regulate Bp through important interactions with the renin-angiotensin and prostaglandin (PG) systems.

Keywords

Adenoma Angiotensin Prostaglandin Indomethacin Verapamil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J.M. Earll, N.A. Kurtzman and R.H. Moser: Hypercalcemia and hypertension. Ann Int. Med 64: 378 (1966).Google Scholar
  2. 2.
    C. Marone, C. Beretta-Piccoli and P. Weidman: Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines and renin. Kidney Int 20: 92 (1980).CrossRefGoogle Scholar
  3. 3.
    H.D. Humes, I. Ichikawa, J.Z. Troy and B.M. Brenner: Evidence for a parathyroid hormone dependent influence of calcium on the glomerular ultrafiltration coefficient. J. Clin Invest 61: 32 (1978).CrossRefGoogle Scholar
  4. 4.
    L. Pedersen: Calcium blockade in arterial hypertension. Hypertension 5: (Suppl II) 74 (1983).Google Scholar
  5. 5.
    J.P. Goldberg, R.W. Schrier: Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin. Min Elect Metab 10: 178 (1984).Google Scholar
  6. 6.
    R. Deth and C. VanBreeman: Relative contributions of Ca2+ influx and cellular Ca2+ release during drug induced activation of the rabbit aorta. Pflugers Arch 348: 13 (1974).CrossRefGoogle Scholar
  7. 7.
    T.K. Keeton and W.B. Campbell: The pharmacologic alteration of renin release. Pharmacol Rev 32: 81 (1981).Google Scholar
  8. 8.
    P.C. Churchill: Second messengers in renin secretion. Am J. Physiol 249: F175 (1985).Google Scholar
  9. 9.
    I. Antonipillai and R. Horton: Role of extra and intracellular calcium and calmodulin in renin release from rat kidney. Endocrinology 117: 601 (1985).CrossRefGoogle Scholar
  10. 10.
    I.A. Reid and W.F. Ganong: Control of aldosterone secretion in: “Hypertension: Pathophysiology and Treatment. J. Genest, E. Koiw and 0. Kuchel eds. McGraw-Hill, New York (1977).Google Scholar
  11. 11.
    F.K. Fujita, G. Aguilera, K.J. Catt: The role of cyclic AMP in aldosterone production by isolated zona glomerulosa cells. J Biol Chem 254: 8567 (1979).Google Scholar
  12. 12.
    R. Foster, M.V. Lobo, H. Rasmussen, E.T. Marusic: Calcium: its role in the mechanism of action of angiotensin II and potassium in aldosterone production Endocrinology 109: 2196 (1981).Google Scholar
  13. 13.
    J.L. Fakunding and K. Catt: Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum and verapamil. Endocrinology 107: 1345 (1980).CrossRefGoogle Scholar
  14. 14.
    M.E. Elliot, P.C. Alexander and T.L. Goodfriend: Aspects of angiotensin action in the adrenal: key roles for calcium and phosphatidylinositol. Hypertension (Suppl II ) 4: 52 (1982).Google Scholar
  15. 15.
    G.P. Guthrie, Jr., R.G. McAllister, Jr., and T.A. Kotchen: Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man. J. Clin Endocrinol Metab 57: 339 (1983).CrossRefGoogle Scholar
  16. 16.
    J.L. Nadler, W. Hsueh and R. Horton: Therapeutic effect of calcium channel blockade in primary aldosteronism. J Clin Endocrinol Metab. 60: 896 (1985).CrossRefGoogle Scholar
  17. 17.
    J. McGiff, K. Crowshaw, N. Terragno and A. Lonigro: Renal prostaglandins possible regulators of the renal actions of pressor hormones. Nature 227: 1255 (1970).CrossRefGoogle Scholar
  18. 18.
    J. Aiken and J. Vane: Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 184: 678 (1973).Google Scholar
  19. 19.
    P. Negus, R. Tannen and M. Dunn: Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man. Prostaglandins 12: 175 (1976).CrossRefGoogle Scholar
  20. 20.
    J. Nadler, R.Zipser, R. Coleman and R. Horton: Stimulation of renal prostaglandins by pressor hormones in man: comparison of PGE2 and PGI2. J Clin Endocrinol Metab 56: 1260 (1983).CrossRefGoogle Scholar
  21. 21.
    L. Levine and M. Moskowitz: α and ß stimulation of arachidonic acid metabolism in cells in culture. Proc Natl. Acad. Sci USA 76: 6632 (1979).CrossRefGoogle Scholar
  22. 22.
    R. Zipser, J. Hoefs, P. Speckart, P. Zia and R. Horton. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 48: 895 (1979).CrossRefGoogle Scholar
  23. 23.
    V. Dzau, M. Packer, L. Lilly, S. Swartz, N. Hollenberg and G. Williams: Prostaglandins in severe congestive heart failure: relations to activation of the renin angiotensin system and hyponatremia. N Eng J Med 310: 347 (1984).CrossRefGoogle Scholar
  24. 24.
    D. Cline and J.S. Stoff: Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 310: 563 (1984).CrossRefGoogle Scholar
  25. 25.
    B. Weksler, C. Ley and E. Jaffee: Stimulation of endothelial cell prostacyclin production by thrombin, trypsin and the ionophore A23187. J Clin Invest. 62: 923 (1978).CrossRefGoogle Scholar
  26. 26.
    H.R. Knapp, O. Oelz, L.J. Roberts, B.J. Sweetman, J.A. Oates and P.W. Reed: Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc. Natl Acad Sci USA 74: 4251 (1977).CrossRefGoogle Scholar
  27. 27.
    J.L. Nadler, M. McKay, V. Campese and R. Horton: Evidence that prostacyclin modulates the vascular actions of calcium in man. J. Clin Invest 77: (1986, in press).Google Scholar
  28. 28.
    J.L. Nadler, R. Zipser and R. Horton: The effect of adrenergic stimulation on urinary prostaglandin E2 and 6 keto PGFlα in man. Prostaglandins 26: 519 (1983).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • J. L. Nadler
    • 1
  • I. Antonipillai
    • 1
  1. 1.Section of EndocrinologyUniversity of Southern California Medical CenterLos AngelesUSA

Personalised recommendations